Preventable infections in children with leukodystrophy

Annals of Clinical and Translational Neurology

Volumn 1, Issue 5, 2014, Pages 370-374

  Anderson, Holly M ^a   Wilkes, Jacob ^b   Korgenski, Ernest Kent ^b   Pulsipher, Michael A ^a   Blaschke, Anne J ^a   Hersh, Adam L ^a   Srivastava, Rajendu ^a   Bonkowsky, Joshua L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; ARTIFICIAL VENTILATION; BRONCHIOLITIS; CELLULITIS; CHILD; COHORT ANALYSIS; HEMATOPOIETIC STEM CELL; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFLUENZA; LEUKODYSTROPHY; MAJOR CLINICAL STUDY; MENINGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SOFT TISSUE INFECTION; TRACHEOSTOMY; URINARY TRACT INFECTION; VACCINATION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84928556433     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.61     Document Type: Article

References (15)

1. Berger J, Moser HW, Forss-Petter S. Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment. Curr Opin Neurol 2001;14:305–312.
2. Kaye EM. Update on genetic disorders affecting white matter. Pediatr Neurol 2001;24:11–24.
3. Raymond G, Eichler F, Fatemi A, Naidu S. Leukodystrophies. 1st ed. London: Mac Keith Press, 2011.
4. Bonkowsky JL, Nelson C, Kingston JL, et al. The burden of inherited leukodystrophies in children. Neurology 2010;75:718–725.
5. Nelson C, Mundorff MB, Korgenski EK, et al. Determinants of health care use in a population-based leukodystrophy cohort. J Pediatr 2013;162:624–628.
6. Krivit W, Aubourg P, Shapiro E, Peters C. Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol 1999;6:377–382.
7. Orchard PJ, Tolar J. Transplant outcomes in leukodystrophies. Semin Hematol 2010;47:70–78.
8. de Ru MH, Boelens JJ, Das AM, et al. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis 2011;6:55.
9. Brimley CJ, Lopez J, van Haren K, et al. National variation in costs and mortality for leukodystrophy patients in US children's hospitals. Pediatr Neurol 2013;49:156–162.e1.
10. Norlin C, Osborn LM. Organizational responses to managed care: issues for academic health centers and implications for pediatric programs. Pediatrics 1998;101:805–811.
11. Age distribution in Utah. Available at: http://governor.utah.gov/dea/Publications/05CensusBriefs2010/2AgeDistribution.pdf. Accessed 23 July 2013.
12. Lemoine TJ, Swoboda KJ, Bratton SL, et al. Spinal muscular atrophy type 1: are proactive respiratory interventions associated with longer survival? Pediatr Crit Care Med 2012;13:e161–e165.
13. Cohen-Cymberknoh M, Shoseyov D, Kerem E. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am J Respir Crit Care Med 2011;183:1463–1471.
14. Gastmeier P, Geffers C. Prevention of catheter-related bloodstream infections: analysis of studies published between 2002 and 2005. J Hosp Infect 2006;64:326–335.
15. Tenke P, Kovacs B, Bjerklund Johansen TE, et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents 2008;31:S68–S78.